Chinese english Germany Japanese Korea

2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)-

2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)- Struktur
154428-10-1
CAS-Nr.
154428-10-1
Englisch Name:
2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)-
Synonyma:
Docetaxel Impurity 45;Docetaxel Impurity 28;2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)-
CBNumber:
CB94766071
Summenformel:
C19H19NO3
Molgewicht:
309.36
MOL-Datei:
154428-10-1.mol
Request For Quotation

2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)- Eigenschaften

Sicherheit

2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14336 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238
 3008233717@qq.com China 9896 12
Jinan blalong chemical co. LTD 2710913286@.com
 1513643261@qq.com China 14253 58
Scinova Biotech(Guangzhou) Co., Ltd. 13268215580
 scinova_sales@163.com China 7026 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
 3287908757@qq.com China 9118 58
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
 hanfangpharma@126.com China 30968 58

154428-10-1()Verwandte Suche:

4,4'-Anisoin
  • 2-Azetidinone, 3-(acetyloxy)-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)-
  • Docetaxel Impurity 28
  • Docetaxel Impurity 45
  • 154428-10-1
Copyright 2019 © ChemicalBook. All rights reserved